AKT1 and diabetes mellitus: Protein kinase B (AKT) activation through mTORC2 activation by Sestrins leads to improved insulin sensitivity in obesity and diabetes (Dong, 2015; Kazyken et al., 2019; Knudsen et al., 2020).